Short-term study in patients treated with desvenlafaxine
Introduction Desvenlafaxine is an antidepressant inhibitor of the reuptake of norepinephrine and serotonin (SNRI). Several publications support its efficacy in reducing depressive symptoms in the short term. Objectives The objective of this paper is to estimate the effect of short-term (12 weeks) of...
Saved in:
Published in: | European psychiatry Vol. 33; no. S1; p. S407 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Masson SAS
01-03-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!